메뉴 건너뛰기
Neurology
Volumn 71, Issue 6, 2008, Pages 390-391
The muddle of mycophenolate mofetil in myasthenia
Author keywords

[No Author keywords available]
Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;
EID: 49049085075     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000324254.97372.e0     Document Type: Editorial
Times cited : (18)
References (8)
  • 1
    • 0031752263 scopus 로고    scopus 로고
    • Successful treatment of a patient with severe refractory myasthenia gravis using my-cophenolate mofetil
    • Hauser RA, Malek AR, Rosen R. Successful treatment of a patient with severe refractory myasthenia gravis using my-cophenolate mofetil. Neurology 1998;51:912-913.
    • (1998) Neurology , vol.51 , pp. 912-913
    • Hauser, R.A.1    Malek, A.R.2    Rosen, R.3
  • 2
    • 0035830428 scopus 로고    scopus 로고
    • Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
    • Chaudhry V, Cornblath DR, Griffin JW, O'Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001;56:94-96.
    • (2001) Neurology , vol.56 , pp. 94-96
    • Chaudhry, V.1    Cornblath, D.R.2    Griffin, J.W.3    O'Brien, R.4    Drachman, D.B.5
  • 3
    • 0035830461 scopus 로고    scopus 로고
    • Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
    • Ciafaloni E, Massey J, Tucker-Lipscomb B, Sanders D. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 2001;56:97-99.
    • (2001) Neurology , vol.56 , pp. 97-99
    • Ciafaloni, E.1    Massey, J.2    Tucker-Lipscomb, B.3    Sanders, D.4
  • 4
    • 0344874547 scopus 로고    scopus 로고
    • Mycophe-nolate mofetil for myasthenia gravis: An analysis of efficacy, safety, and tolerability
    • Meriggioli MN, Ciafaloni E, Al-Hayk KA, et al. Mycophe-nolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability. Neurology 2003;61:1438-1440.
    • (2003) Neurology , vol.61 , pp. 1438-1440
    • Meriggioli, M.N.1    Ciafaloni, E.2    Al-Hayk, K.A.3
  • 5
    • 0141615801 scopus 로고    scopus 로고
    • My-cophenolate mofetil for myasthenia gravis. A double-blind, placebo-controlled pilot study
    • Meriggioloi MN, Rowin J, Richman JG, Leurgans S. My-cophenolate mofetil for myasthenia gravis. A double-blind, placebo-controlled pilot study. Ann NY Acad Sci 2003; 998:494-499.
    • (2003) Ann NY Acad Sci , vol.998 , pp. 494-499
    • Meriggioloi, M.N.1    Rowin, J.2    Richman, J.G.3    Leurgans, S.4
  • 7
    • 44249093570 scopus 로고    scopus 로고
    • An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
    • Sanders DB, Hart IK, Mantegazza R, et al. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 2008;71:400-406.
    • (2008) Neurology , vol.71 , pp. 400-406
    • Sanders, D.B.1    Hart, I.K.2    Mantegazza, R.3
  • 8
    • 49049115186 scopus 로고    scopus 로고
    • A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis
    • Muscle Study Group
    • Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology 2008;71:394-399.
    • (2008) Neurology , vol.71 , pp. 394-399

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.